Predictors of cardiovascular implantable electronic device dependence at long-term follow-up after alcohol septal ablation in hypertrophic cardiomyopathy patients
Background The most common complication of alcohol septal ablation (ASA) is transient periprocedural high-grade AV block (HGAVB). To date, no long-term follow-up of cardiovascular implantable electronic device (CIED) utilization after ASA has been reported. We hypothesized that CIED dependence on lo...
Gespeichert in:
| Veröffentlicht in: | Journal of interventional cardiac electrophysiology 2023-12, Vol.66 (9), p.2071-2080 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2080 |
|---|---|
| container_issue | 9 |
| container_start_page | 2071 |
| container_title | Journal of interventional cardiac electrophysiology |
| container_volume | 66 |
| creator | Bode, Weeranun D. Bode, Michael F. Zhao, Megan Palacios, Igor Sakhuja, Rahul Fifer, Michael A. Mela, Theofanie |
| description | Background
The most common complication of alcohol septal ablation (ASA) is transient periprocedural high-grade AV block (HGAVB). To date, no long-term follow-up of cardiovascular implantable electronic device (CIED) utilization after ASA has been reported. We hypothesized that CIED dependence on long-term follow-up can be predicted by ECG or procedural characteristics.
Methods
We analyzed all patients with HCM who underwent ASA from December 1998 to December 2019 and received their first CIED within 30 days after ASA for HGAVB. All follow-up interrogations were reviewed. CIED dependence was defined as ventricular pacing of ≥ 5%.
Results
A total of 138 patients with HCM underwent ASA. Of these, 35 had a prior device and were excluded. Of the remaining 103 patients, 25 patients received a CIED for HGAVB within 30 days after ASA. Average follow-up duration was 10.1 years. On long-term follow-up, 16 patients (64%) were found to be CIED-dependent. Baseline characteristics, including pre- and post-ASA ECG, were not significantly different between dependent and non-dependent patients. The only predictor for CIED dependence was > 1 ml of alcohol injected (OR 6.0,
p
= 0.031).
Conclusions
CIED implantation after ASA is common. Almost two thirds of patients who received a CIED for post-procedural HGAVB were CIED-dependent on long-term follow-up. CIED dependence can be predicted by the amount of injected alcohol > 1 ml.
Graphical Abstract |
| doi_str_mv | 10.1007/s10840-023-01532-w |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2800148512</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2896599288</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-e301e8b3fccbf11be25711766c1fff7b7feb70ca282d4a871d003e67171814693</originalsourceid><addsrcrecordid>eNp9kc2O1iAUhonROOPoDbgwJG7cVA_QFro0E_-SSXSh64bSw3xMKFSg8-W7Ha9UtONPXLjhEHjOcwgvIU8ZvGQA8lVmoFpogIsGWCd4c7xHzlkneaO6obv_1_6MPMr5BgAG4P1DciYktAIGcU6-fUo4O1NiyjRaanSaXbzV2WxeJ-qW1etQ9OSRokdTUgzO0BlvncFaVgwzhrrVhfoYrpuCaaE2eh-PzbZSbesB1d7EQ_Q041q0p9Wmi4uBukAPpxVTta6Hqt2HL6e46nI40bo6DCU_Jg-s9hmf3NUL8uXtm8-X75urj-8-XL6-aozgfWlQAEM1CWvMZBmbkHeSMdn3hllr5SQtThKM5orPrVaSzQACe8kkU6ztB3FBXuzeNcWvG-YyLi4b9PUHMG555AqAtapjvKLP_0Fv4pZCfV2lhr4bBq5UpfhOmRRzTmjHNblFp9PIYPyR4LgnONYEx58Jjsfa9OxOvU0Lzr9bfkVWAbEDuV6Fa0x_Zv9H-x2u_Kto</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2896599288</pqid></control><display><type>article</type><title>Predictors of cardiovascular implantable electronic device dependence at long-term follow-up after alcohol septal ablation in hypertrophic cardiomyopathy patients</title><source>Springer Nature - Complete Springer Journals</source><creator>Bode, Weeranun D. ; Bode, Michael F. ; Zhao, Megan ; Palacios, Igor ; Sakhuja, Rahul ; Fifer, Michael A. ; Mela, Theofanie</creator><creatorcontrib>Bode, Weeranun D. ; Bode, Michael F. ; Zhao, Megan ; Palacios, Igor ; Sakhuja, Rahul ; Fifer, Michael A. ; Mela, Theofanie</creatorcontrib><description>Background
The most common complication of alcohol septal ablation (ASA) is transient periprocedural high-grade AV block (HGAVB). To date, no long-term follow-up of cardiovascular implantable electronic device (CIED) utilization after ASA has been reported. We hypothesized that CIED dependence on long-term follow-up can be predicted by ECG or procedural characteristics.
Methods
We analyzed all patients with HCM who underwent ASA from December 1998 to December 2019 and received their first CIED within 30 days after ASA for HGAVB. All follow-up interrogations were reviewed. CIED dependence was defined as ventricular pacing of ≥ 5%.
Results
A total of 138 patients with HCM underwent ASA. Of these, 35 had a prior device and were excluded. Of the remaining 103 patients, 25 patients received a CIED for HGAVB within 30 days after ASA. Average follow-up duration was 10.1 years. On long-term follow-up, 16 patients (64%) were found to be CIED-dependent. Baseline characteristics, including pre- and post-ASA ECG, were not significantly different between dependent and non-dependent patients. The only predictor for CIED dependence was > 1 ml of alcohol injected (OR 6.0,
p
= 0.031).
Conclusions
CIED implantation after ASA is common. Almost two thirds of patients who received a CIED for post-procedural HGAVB were CIED-dependent on long-term follow-up. CIED dependence can be predicted by the amount of injected alcohol > 1 ml.
Graphical Abstract</description><identifier>ISSN: 1572-8595</identifier><identifier>ISSN: 1383-875X</identifier><identifier>EISSN: 1572-8595</identifier><identifier>DOI: 10.1007/s10840-023-01532-w</identifier><identifier>PMID: 37043093</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Ablation ; Alcohol ; Alcohols ; Cardiology ; Cardiomyopathy ; EKG ; Medicine ; Medicine & Public Health ; Ventricle</subject><ispartof>Journal of interventional cardiac electrophysiology, 2023-12, Vol.66 (9), p.2071-2080</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-e301e8b3fccbf11be25711766c1fff7b7feb70ca282d4a871d003e67171814693</cites><orcidid>0000-0002-3128-1269</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10840-023-01532-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10840-023-01532-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37043093$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bode, Weeranun D.</creatorcontrib><creatorcontrib>Bode, Michael F.</creatorcontrib><creatorcontrib>Zhao, Megan</creatorcontrib><creatorcontrib>Palacios, Igor</creatorcontrib><creatorcontrib>Sakhuja, Rahul</creatorcontrib><creatorcontrib>Fifer, Michael A.</creatorcontrib><creatorcontrib>Mela, Theofanie</creatorcontrib><title>Predictors of cardiovascular implantable electronic device dependence at long-term follow-up after alcohol septal ablation in hypertrophic cardiomyopathy patients</title><title>Journal of interventional cardiac electrophysiology</title><addtitle>J Interv Card Electrophysiol</addtitle><addtitle>J Interv Card Electrophysiol</addtitle><description>Background
The most common complication of alcohol septal ablation (ASA) is transient periprocedural high-grade AV block (HGAVB). To date, no long-term follow-up of cardiovascular implantable electronic device (CIED) utilization after ASA has been reported. We hypothesized that CIED dependence on long-term follow-up can be predicted by ECG or procedural characteristics.
Methods
We analyzed all patients with HCM who underwent ASA from December 1998 to December 2019 and received their first CIED within 30 days after ASA for HGAVB. All follow-up interrogations were reviewed. CIED dependence was defined as ventricular pacing of ≥ 5%.
Results
A total of 138 patients with HCM underwent ASA. Of these, 35 had a prior device and were excluded. Of the remaining 103 patients, 25 patients received a CIED for HGAVB within 30 days after ASA. Average follow-up duration was 10.1 years. On long-term follow-up, 16 patients (64%) were found to be CIED-dependent. Baseline characteristics, including pre- and post-ASA ECG, were not significantly different between dependent and non-dependent patients. The only predictor for CIED dependence was > 1 ml of alcohol injected (OR 6.0,
p
= 0.031).
Conclusions
CIED implantation after ASA is common. Almost two thirds of patients who received a CIED for post-procedural HGAVB were CIED-dependent on long-term follow-up. CIED dependence can be predicted by the amount of injected alcohol > 1 ml.
Graphical Abstract</description><subject>Ablation</subject><subject>Alcohol</subject><subject>Alcohols</subject><subject>Cardiology</subject><subject>Cardiomyopathy</subject><subject>EKG</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Ventricle</subject><issn>1572-8595</issn><issn>1383-875X</issn><issn>1572-8595</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kc2O1iAUhonROOPoDbgwJG7cVA_QFro0E_-SSXSh64bSw3xMKFSg8-W7Ha9UtONPXLjhEHjOcwgvIU8ZvGQA8lVmoFpogIsGWCd4c7xHzlkneaO6obv_1_6MPMr5BgAG4P1DciYktAIGcU6-fUo4O1NiyjRaanSaXbzV2WxeJ-qW1etQ9OSRokdTUgzO0BlvncFaVgwzhrrVhfoYrpuCaaE2eh-PzbZSbesB1d7EQ_Q041q0p9Wmi4uBukAPpxVTta6Hqt2HL6e46nI40bo6DCU_Jg-s9hmf3NUL8uXtm8-X75urj-8-XL6-aozgfWlQAEM1CWvMZBmbkHeSMdn3hllr5SQtThKM5orPrVaSzQACe8kkU6ztB3FBXuzeNcWvG-YyLi4b9PUHMG555AqAtapjvKLP_0Fv4pZCfV2lhr4bBq5UpfhOmRRzTmjHNblFp9PIYPyR4LgnONYEx58Jjsfa9OxOvU0Lzr9bfkVWAbEDuV6Fa0x_Zv9H-x2u_Kto</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Bode, Weeranun D.</creator><creator>Bode, Michael F.</creator><creator>Zhao, Megan</creator><creator>Palacios, Igor</creator><creator>Sakhuja, Rahul</creator><creator>Fifer, Michael A.</creator><creator>Mela, Theofanie</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3128-1269</orcidid></search><sort><creationdate>20231201</creationdate><title>Predictors of cardiovascular implantable electronic device dependence at long-term follow-up after alcohol septal ablation in hypertrophic cardiomyopathy patients</title><author>Bode, Weeranun D. ; Bode, Michael F. ; Zhao, Megan ; Palacios, Igor ; Sakhuja, Rahul ; Fifer, Michael A. ; Mela, Theofanie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-e301e8b3fccbf11be25711766c1fff7b7feb70ca282d4a871d003e67171814693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Ablation</topic><topic>Alcohol</topic><topic>Alcohols</topic><topic>Cardiology</topic><topic>Cardiomyopathy</topic><topic>EKG</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Ventricle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bode, Weeranun D.</creatorcontrib><creatorcontrib>Bode, Michael F.</creatorcontrib><creatorcontrib>Zhao, Megan</creatorcontrib><creatorcontrib>Palacios, Igor</creatorcontrib><creatorcontrib>Sakhuja, Rahul</creatorcontrib><creatorcontrib>Fifer, Michael A.</creatorcontrib><creatorcontrib>Mela, Theofanie</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of interventional cardiac electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bode, Weeranun D.</au><au>Bode, Michael F.</au><au>Zhao, Megan</au><au>Palacios, Igor</au><au>Sakhuja, Rahul</au><au>Fifer, Michael A.</au><au>Mela, Theofanie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictors of cardiovascular implantable electronic device dependence at long-term follow-up after alcohol septal ablation in hypertrophic cardiomyopathy patients</atitle><jtitle>Journal of interventional cardiac electrophysiology</jtitle><stitle>J Interv Card Electrophysiol</stitle><addtitle>J Interv Card Electrophysiol</addtitle><date>2023-12-01</date><risdate>2023</risdate><volume>66</volume><issue>9</issue><spage>2071</spage><epage>2080</epage><pages>2071-2080</pages><issn>1572-8595</issn><issn>1383-875X</issn><eissn>1572-8595</eissn><abstract>Background
The most common complication of alcohol septal ablation (ASA) is transient periprocedural high-grade AV block (HGAVB). To date, no long-term follow-up of cardiovascular implantable electronic device (CIED) utilization after ASA has been reported. We hypothesized that CIED dependence on long-term follow-up can be predicted by ECG or procedural characteristics.
Methods
We analyzed all patients with HCM who underwent ASA from December 1998 to December 2019 and received their first CIED within 30 days after ASA for HGAVB. All follow-up interrogations were reviewed. CIED dependence was defined as ventricular pacing of ≥ 5%.
Results
A total of 138 patients with HCM underwent ASA. Of these, 35 had a prior device and were excluded. Of the remaining 103 patients, 25 patients received a CIED for HGAVB within 30 days after ASA. Average follow-up duration was 10.1 years. On long-term follow-up, 16 patients (64%) were found to be CIED-dependent. Baseline characteristics, including pre- and post-ASA ECG, were not significantly different between dependent and non-dependent patients. The only predictor for CIED dependence was > 1 ml of alcohol injected (OR 6.0,
p
= 0.031).
Conclusions
CIED implantation after ASA is common. Almost two thirds of patients who received a CIED for post-procedural HGAVB were CIED-dependent on long-term follow-up. CIED dependence can be predicted by the amount of injected alcohol > 1 ml.
Graphical Abstract</abstract><cop>New York</cop><pub>Springer US</pub><pmid>37043093</pmid><doi>10.1007/s10840-023-01532-w</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-3128-1269</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1572-8595 |
| ispartof | Journal of interventional cardiac electrophysiology, 2023-12, Vol.66 (9), p.2071-2080 |
| issn | 1572-8595 1383-875X 1572-8595 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2800148512 |
| source | Springer Nature - Complete Springer Journals |
| subjects | Ablation Alcohol Alcohols Cardiology Cardiomyopathy EKG Medicine Medicine & Public Health Ventricle |
| title | Predictors of cardiovascular implantable electronic device dependence at long-term follow-up after alcohol septal ablation in hypertrophic cardiomyopathy patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T17%3A48%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictors%20of%20cardiovascular%20implantable%20electronic%20device%20dependence%20at%20long-term%20follow-up%20after%20alcohol%20septal%20ablation%20in%20hypertrophic%20cardiomyopathy%20patients&rft.jtitle=Journal%20of%20interventional%20cardiac%20electrophysiology&rft.au=Bode,%20Weeranun%20D.&rft.date=2023-12-01&rft.volume=66&rft.issue=9&rft.spage=2071&rft.epage=2080&rft.pages=2071-2080&rft.issn=1572-8595&rft.eissn=1572-8595&rft_id=info:doi/10.1007/s10840-023-01532-w&rft_dat=%3Cproquest_cross%3E2896599288%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2896599288&rft_id=info:pmid/37043093&rfr_iscdi=true |